Novaglipt

Novaglipt is a vildagliptin tablet, a DPP-4 inhibitor for effective type 2 diabetes glucose control.

Type:

Tablet

Classification:

Antidiabetic

#VILDAGLIPTIN #DPP4 #DIABETES #TYPE2 #ANTIDIABETIC

Novaglipt Product Image

Product Overview

Novaglipt is a DPP-4 inhibitor providing incretin-based glucose control for type 2 diabetes management.

Composition

  • Vildagliptin tablet - DPP-4 inhibitor

Indications

  • Type 2 diabetes mellitus management
  • Fasting and postprandial glucose control
  • HbA1c reduction
  • Monotherapy or combination therapy
  • Weight-neutral glucose control

Marketed By

Vee Medi Biotech